Tous Actualités
Suivre
Abonner AEVIS Holding SA

AEVIS Holding SA

DGAP-Adhoc: AEVIS Holding SA increases its 2.75% straight bond issued in June 2014

EQS Group-Ad-hoc: AEVIS Holding SA / Key word(s): Bond
AEVIS Holding SA increases its 2.75% straight bond issued in June 2014

02.12.2014 / 20:14
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------

THIS DOCUMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN
INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE FOR SECURITIES. THE
OFFER OF THE INSTRUMENT OUTLINED HEREIN IS PROHIBITED OR RESTRICTED IN
VARIOUS JURISDICTIONS INCLUDING THE UNITED STATES, THE EUROPEAN ECONOMIC
AREA AND THE UK.

AEVIS Holding SA announces the increase of its 5-Year straight bond that
was issued in June 2014. Due to attractive market conditions, the bond is
increased by CHF 20 million to a new total of CHF 145 million. The net
proceeds of the bond increase will be used for general corporate purposes
including potential future acquisitions and refinancing of existing debts.
UBS AG acted as Lead Manager of the bonds. The key terms are as follows:

Issuer: AEVIS Holding SA, Fribourg, Switzerland
Amount increased: CHF 20'000'000
Total amount issued: CHF 145'000'000
Coupon: 2.75% p.a.
Term: 5 Years
Issue price: 101.75% + 191 days accrued interest
Redemption: 100%
Payment date: 15 December 2014
Listing: Listing will be applied in accordance with the standard for bonds
of the SIX Swiss Exchange

For further information:
AEVIS Holding AG Media and Investor Relations:
c/o Dynamics Group, Zurich
Edwin van der Geest,  vdg@dynamicsgroup.ch,
+41 (0) 43 268 32 35 or +41 (0) 79 330 55 22
Philippe R. Blangey,  prb@dynamicsgroup.ch,
+41 (0) 43 268 32 35 or +41 (0) 79 785 46 32

AEVIS Holding SA
AEVIS Holding SA invests in services to people, healthcare, life sciences,
hotels and lifestyle. AEVIS's main shareholdings are Genolier Swiss Medical
Network, the second largest group of private clinics in Switzerland,
Victoria-Jungfrau Collection AG, a luxury hotel group managing four palace
hotels in Switzerland, Swiss Healthcare Properties AG, a company
specialised in medical real estate, Nescens SA, a brand dedicated to better
aging, and AS Ambulances Services SA. AEVIS wishes to progressively develop
new sectors of activity, amongst others in the sector of outpatient
surgical centres, radiology or dental medicine, in hotel or hotel-related
activities. AEVIS is listed on the Domestic Standard segment of the SIX
Swiss Exchange under the ticker AEVS.SW.

 
DISCLAIMER

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL, A SOLICITATION OF
AN OFFER TO BUY ANY OF THE BONDS DESCRIBED HEREIN, OR ANY KIND OF ADVICE,
NOR SHALL THERE BE ANY OFFER, SOLICITATION OR SALE IN ANY COUNTRY OR
JURISDICTION IN WHICH SUCH AN OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL
PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY
COUNTRY OR JURISDICTION. THIS PRESS RELEASE ALSO DOES NOT CONSTITUTE A
PROSPECTUS AS SUCH TERM IS UNDERSTOOD PURSUANT TO ARTICLE 652A OR ARTICLE
1156 OF THE SWISS FEDERAL CODE OF OBLIGATIONS OR A LISTING PROSPECTUS
WITHIN THE MEANING OF THE LISTING RULES OF THE SIX SWISS EXCHANGE.

THE RELEVANT INFORMATION ON THE BONDS AND THE ISSUER IS ONLY AVAILABLE IN
THE FINAL PROSPECTUS WHICH IS CURRENTLY EXPECTED TO BE AVAILABLE ON 11
DECEMBER 2014 (THE "PROSPECTUS"). THE BONDS ARE SUBJET TO THE SELLING
RESTRICTIONS SET OUT IN THE PROSPECTUS. THE PROSPECTUS IS AVAILABLE FREE OF
CHARGE AT UBS AG, PROSPECTUS LIBRARY, P.O. BOX, CH-8098 ZURICH,
SWITZERLAND, AND CAN BE ORDERED BY TELEPHONE (+41 44 239 47 03), FAX (+41
44 239 69 14) OR BY E-MAIL (SWISS-PROSPECTUS@UBS.COM).

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR
DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA AND MUST NOT BE
DISTRIBUTED TO U.S. PERSONS (AS DEFINED IN REGULATION S OF THE U.S.
SECURITIES ACT OF 1933, AS AMENDED ("SECURITIES ACT")) OR TO PUBLICATIONS
WITH A GENERAL CIRCULATION IN THE UNITED STATES. THE SECURITIES REFERRED TO
HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT OR
ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD IN THE UNITED
STATES ABSENT REGISTRATION OR AN APPLICABLE EXEMPTION FROM SUCH
REGISTRATION REQUIREMENTS.

IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") THIS ANNOUNCEMENT
AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED ONLY AT PERSONS WHO ARE
"QUALIFIED INVESTORS" WITHIN THE MEANING OF ARTICLE 2(1)(E) OF DIRECTIVE
2003/71/EC, AS AMENDED BY THE DIRECTIVE 2010/73/EC (THE "PROSPECTUS
DIRECTIVE").

WITHIN THE UNITED KINGDOM, THIS ANNOUNCEMENT IS DIRECTED ONLY AT PERSONS
HAVING PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL
WITHIN THE DEFINITION OF "INVESTMENT PROFESSIONALS" IN ARTICLE 19(5) OF THE
FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005
("RELEVANT PERSONS"). THE INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS
ANNOUNCEMENT RELATES IS ONLY AVAILABLE TO AND WILL ONLY BE ENGAGED IN WITH
RELEVANT PERSONS AND PERSON WHO RECEIVE THIS ANNOUNCEMENT WHO ARE NOT
RELEVANT PERSONS SHOULD NOT RELY OR ACT UPON IT.
End of ad hoc announcement

---------------------------------------------------------------------

02.12.2014 News transmitted by EQS Schweiz AG. www.eqs.com - news
archive: http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release.

---------------------------------------------------------------------


301885 02.12.2014

Plus de actualités: AEVIS Holding SA
Plus de actualités: AEVIS Holding SA